To better equip researchers, Neuromics continuously strives to expand our portfolio of human cells and tissue. This past week, we've done just that, adding two new lines of human brain cancer cells.
The first new cells are LN-319 cells, a line of tumorigenic human brain epithelial cells. LN-319 cells are derived from a left malignant glioma of a 69 year old Caucasian male with anaplastic astrocytoma grade III.
The second line of cells is SF-295 cells. These cells are derived from the tumor of a 67 year-old female glioblastoma patient.
Image: Fluorescence images of colorectal tumor CAFs (Cat.# CAF115) cultured in CoAl hydrogels counterstained with live (green) / dead (red) dyes (top, scale bar=200 µm) and nucleus (blue) / F-actin (red) (bottom, scale bar=20 µm). Courtesy of Huan Cao, et al., Nanyang Technological University
Learn more about these cells...
In addition to these two cancer cell lines, we have many other human cells with applications in cancer research. Our Cancer Associated Fibroblasts (CAFs) continue to be some of our most popular cells. Check out this blog post to learn about how researchers have been using them recently. We also have a wide selection of GFP-expressing and RFP-expressing human cancer cells available. Check out all of the aforementioned cells here.
Learn more about the SF-295 and LN-319 cells below.
|LN-319 Cells||LN001||Primary Cells||Human||Cell Assays||500,000 Cells||$990.00|
|SF-295 Cells||SF001||Primary Cells||Human||Cell Assays||500,000 Cells||$522.00|